1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
Clinical Trial Management (CTM) Market: Global Opportunity Analysis and Industry Forecast, 2017-2023

Clinical Trial Management (CTM) Market: Global Opportunity Analysis and Industry Forecast, 2017-2023

  • February 2018
  • 214 pages
  • ID: 5371902

Summary

Table of Contents

Clinical Trial Management (CTM) Market by Delivery Mode (Web-based CTM, On-premise, and Cloud-based CTM), Product Type (Enterprise-based and Site-based), Component (Software, Hardware, and Services), and End Users (Pharmaceutical and Biopharmaceutical Companies, Clinical Research Organizations, and Healthcare Providers): Global Opportunity Analysis and Industry Forecast, 2017-2023

The global clinical trial management market was valued at $570 million in 2016, and is estimated to reach $1,371 million by 2023, registering a CAGR of 13.4% from 2017 to 2023. Clinical trial management system (CTMS) is a software used for managing clinical trials of usually biotechnology and pharmaceutical industries. The high efficiency of the system to maintain & manage plans, perform & report functions, as well as store participant contact information, and track deadlines boost the market growth.

Increase in adoption of clinical trial management system (CTMS) in clinical trials, growth in the number of clinical trials, increase in trend of outsourcing of clinical trials, favorable government initiatives supporting the use of CTMS, and increase in awareness regarding the benefits of using CTM. However, dearth of skilled professionals to operate advanced CTMS solutions and high cost and data security issue of CTMS solutions restrain the market growth. Conversely, rise in R&D activities and expenditure of pharmaceutical and bio-pharmaceutical companies provides lucrative opportunities for the market growth.

The global clinical trials management system market is segmented based on product type, component, delivery mode, end user, and region. Based on product, it is bifurcated into enterprise-based and site-based. Based on the component, it is divided into hardware, software, and services. Based on mode of delivery, it is categorized into web-based CTMS, on-premise, and cloud-based CTMS. Based on end user, it is classified into pharmaceutical & biopharmaceutical companies, clinical research organizations, and healthcare providers. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY MARKET BENEFITS FOR STAKEHOLDERS
This report offers a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
In-depth analysis based on region facilitates in analyzing the regional market to assist in strategic business planning.
The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.

KEY MARKET SEGMENTS

By Delivery Mode
Web-based CTMS
On-premise
Cloud-based CTMS

By Product Type
Enterprise-based
Site-based

By Component
Software
Hardware
Services

By End Users
Pharmaceutical and Biopharmaceutical Companies
Clinical Research Organizations
Healthcare Providers

By Region
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

KEY PLAYERS PROFILED
Oracle
Medidata Solutions
Parexel
BioClinica, Inc.
Bio-Optronics
IBM
MedNet Solutions
Veeva Systems
Forte Research Systems
Merge Healthcare Incorporated

The other players of the Clinical Trial Management market include (companies not profiled in the report):
Mednet Solutions
Arisglobal
eClinForce Inc.
DZS Software Solutions
DSG, Inc.
Guger Technologies Inc.
ICON, Plc.
ChemWare Inc.
iWeb Technologies Limited

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H2, 2018

Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H2, 2018

  • $ 2500
  • October 2018

Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H2, 2018SummaryGlobalData’s clinical trial report, “Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H2, 2018" provides an overview ...

Clinical Research in Venous Thromboembolism in H2, 2018

Clinical Research in Venous Thromboembolism in H2, 2018

  • $ 2500
  • September 2018

Venous Thromboembolism Global Clinical Trials Review, H2, 2018SummaryGlobalData’s clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H2, 2018" provides an overview of Venous ...

Clinical Research in Tuberculosis in H2, 2018

Clinical Research in Tuberculosis in H2, 2018

  • $ 2500
  • September 2018

Tuberculosis Global Clinical Trials Review, H2, 2018SummaryGlobalData’s clinical trial report, “Tuberculosis Global Clinical Trials Review, H2, 2018" provides an overview of Tuberculosis clinical trials ...


ref:plp2018

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on